Listen at minute mark 23:00 where Gomez says that they are in the process of spinning off DNAPrint Pharmaceuticals and would like to eventually take it public.
Believes the company is presently worth in the $35 million range. Is looking for $10,000,000 Series B round with which they believe can take the company value to $86,000,000 in twelve months. Would look for a Series C injection after a year of $50,000,000 that would take us to $149,000,000 valuation.